Physician profile
Stacey Zingoni
NPI 1548794456
$1,080.07
in general payments reported to CMS, 2019-2025
10 companies · $48.35 in 2025
The $48.35 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $143 · 2022: $280 · 2023: $131 · 2024: $479 · 2025: $48.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $657.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $327.75 | 2024-2025 | Assure Wcd |
| Atricure, INC. | $243.60 | 2021-2023 | |
| Boston Scientific Corporation | $146.78 | 2022 | |
| Edwards Lifesciences Corporation | $133.00 | 2022 | |
| Cvrx, INC. | $116.89 | 2024 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.17 | 2024 | Jardiance |
| Shionogi INC | $29.80 | 2023 | Fetroja |
| Astrazeneca Pharmaceuticals LP | $23.92 | 2024 | Farxiga |
| Haemonetics Corporation | $22.96 | 2024 | Teg6s Hemostasis System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $2.20 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Zingoni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.